Creo Medical Group Plc CREO
LSE · United Kingdom · Health Technology
GBp 9.74-0.66 (-6.35%)
Market open· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
The UK market has been navigating choppy waters, with the FTSE 100 recently closing lower due to weak trade data from China, highlighting global economic uncertainties. In such a climate, investors often seek opportunities in less conventional areas like penny stocks, which despite their outdated moniker, can still represent smaller or emerging companies with potential for growth. By focusing on those with solid financial foundations and promising business models, investors may find...
Looking at Creo Medical Group PLC's ( LON:CREO ) insider transactions over the last year, we can see that insiders were...
Creo Medical Group PLC (AIM:CREO, FRA:1RC, OTC:CMEOF), the medical device company specialising in minimally invasive surgical endoscopy, saw its shares jump 27% to 14.44p after announcing plans to sell its remaining 49% interest in Creo Medical Europe alongside a placing and full-year...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.